RxDoctor Payments Data

Brigitta Bittner, MD

Family Medicine · Lafayette, INNPI 1588254726

Payments from drug & device makers

$471in general payments, 2019–2025

Across 12 payments — averaging $39.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$168
  • Exact Sciences$77
  • Axsome Therapeutics, Inc.$76
  • Inspire Medical Systems, Inc.$46
  • Novo Nordisk$46
  • Pfizer$39
  • plus $19 from 1 others

What the payments were for

  • Food & beverage$471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$471 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$207,732
Medicare patients
561
Services billed
2,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$122,853
JardianceEmpagliflozin96$108,108
EliquisApixaban94$91,776
JanuviaSitagliptin Phosphate52$67,125
MounjaroTirzepatide51$51,968
TrulicityDulaglutide32$37,419
XareltoRivaroxaban27$25,751
MyrbetriqMirabegron20$19,350
FarxigaDapagliflozin Propanediol29$16,501
Victoza 3-PakLiraglutide12$12,529
Aimovig AutoinjectorErenumab-Aooe16$11,558
Lantus SolostarInsulin Glargine,hum.Rec.Anlog72$10,441
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,360
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$8,071
LinzessLinaclotide12$7,567

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$46$122,85387 claims
PfizerEliquis$39$91,77694 claims
AstraZenecaFarxiga, Symbicort$168$22,38748 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →